Eli Lilly trial update on kidney drug hurts Tectonic

Shares of Tectonic Therapeutic (NASDAQ:TECX) plunged on Tuesday after a federal website on clinical trials indicated that Eli Lilly (NYSE:LLY) has terminated a mid-stage trial for its experimental kidney disease therapy volenrelaxin, a treatment similar to TECX’s lead